MULTIPLE SCLEROSIS AND RELATED DISORDERS, vol.58, 2022 (Peer-Reviewed Journal)
Article / Article
MULTIPLE SCLEROSIS AND RELATED DISORDERS
Science Citation Index Expanded, Scopus, EMBASE, MEDLINE
Neuromyelitis optica spectrum disorders, Myelin oligodendrocyte glycoprotein antibody-associated disorders, Disease modifying treatment, Coronavirus, SARS-CoV-2
Background: COVID-19 is a multisystemic infection with variables consequences depending on individual and comorbid conditions. The course and outcomes of COVID-19 during neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) are not clearly known.